Founding Year2018TractionPoppins has undergone numerous preliminary studies, involving over 6,000 families across France, and has demonstrated clinical benefit through comparative clinical trials.Organizations InvolvedMAE, Allianz France, Abeille Assurance, Groupe Pasteur Mutualité, PRO BTP, IRCEM, Kerialis, Audiens, Radio FranceFoundersFrançois Vonthron, Antoine YuenMarketDyslexia therapy for childrenLocationFranceCoinvestorsRacine2, Bpifrance’s Patient Autonome fund, Eurazeo, Kurma Partners, BNP Paribas Développement, Verve Ventures Company Description
Poppins is a startup specializing in medical devices for managing neurodevelopmental disorders, particularly dyslexia, which accounts for 80% of learning disorders. The medical device offers a structured training protocol through a video game comprising 31 written language and rhythm exercises, accessible on a tablet or smartphone.